Brief: Ovoca Bio Gets Marketing Nod For Orenetide In Russia

Talisman Metals

22/02/2022 15:33

Feb 22 (Reuters) - Ovoca Bio PLC  OVB.L :
    * OVOCA BIO PLC - DISCUSSIONS REGARDING PARTNERSHIP FOR
COMMERCIALISATION OF ORENETIDE IN RUSSIAN FEDERATION ONGOING
    * OVOCA BIO - GETS MARKETING APPROVAL FOR ORENETIDE FOR
TREATMENT
OF HYPOACTIVE SEXUAL DESIRE DISORDER IN PREMENOPAUSAL WOMEN IN
RUSSIAN FEDERATION
    * OVOCA BIO PLC - APPROVED MANUFACTURING SITE FOR ORENETIDE
WILL
BE OPERATED BY TWO REPUTABLE PHARMACEUTICAL MANUFACTURERS -
NATIVA AND ONCOTARGET
    * OVOCA BIO PLC - COMMERCIAL PRODUCTION OF ORENETIDE
EXPECTED TO
START IN SPRING 2022
    * OVOCA BIO PLC - ALSO CONTINUING OUR DEVELOPMENT PROGRAMME
FOR
ORENETIDE IN A WIDER INTERNATIONAL MARKETS WHICH ARE OVOCA'S
PRINCIPAL TARGET

Source text for Eikon:  ID:nRSV4664Ca 
Further company coverage:  OVB.L 

 ((Reuters.Briefs@thomsonreuters.com;))